Roche Diabetes Care

When accuracy is everything

Roche Diabetes Care has been pioneering innovative diabetes technologies and services for more than 40 years.

Being a global leader in integrated diabetes management, more than 5,000 employees in over 100 markets worldwide work every day to support people with diabetes and those at risk to achieve more time in their target range and experience true relief from the daily therapy routines

Roche Diabetes Care collaborates with caregivers, healthcare providers and payors to optimally manage this complex condition and contribute to sustainable care structures. Under the brand Accu-Chek and in collaboration with partners, Roche Diabetes Care creates value by providing integrated solutions to monitor glucose levels, deliver insulin and track as well as contextualize relevant data points for a successful therapy.

By establishing a leading open ecosystem, connecting devices, digital solutions, Roche Diabetes Care will enable optimal personalised diabetes management and thus improve therapy outcomes. Since 2017, mySugr, with its world leading mobile diabetes management app and services is part of Roche Diabetes Care.

Accu-Chek Website

Roche Products Pty Limited ABN 70 000 132 865 | Roche Diagnostics Australia Pty Limited ABN 29 003 001 205 | Roche Diabetes Care Australia Pty Limited ABN 69 602 140 278. This website may contain information about products that are not registered for use in your country of residence and may not comply with applicable laws or regulations in that country. We do not take any responsibility for accessing such information in those circumstances. This site is not intended or designed for reporting of adverse events. To report an adverse event please contact the Roche Australia Drug Safety Department immediately on Australia.drug_safety@roche.com or on +61 (0)2 9454 9444.